Orchestra BioMed Holdings, Inc. (OBIO): Depreciation & Amortization

Annual figures by period end, from SEC filings.

$327.0K

Year ended 2025-12-31

$349.0K

Trailing 12 months to 2026-06-30

+13.8%

3-year compound annual growth

2022-12-31 Depreciation & Amortization (USD) 2025-12-31

Period ended	Depreciation & Amortization	Change YoY	Source filing
2025-12-31	$327.0K	+6.2%	2026-03-12, From 2025-01-01
2024-12-31	$308.0K	+7.3%	2026-03-12, From 2024-01-01
2023-12-31	$287.0K	+29.3%	2025-03-31, From 2023-01-01
2022-12-31	$222.0K	n/a	2024-03-27, From 2022-01-01

Depreciation & Amortization at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Depreciation & Amortization	Change YoY
Orchestra BioMed Holdings, Inc. (OBIO)	2025-12-31	$327.0K	+6.2%
Premier Air Charter Holdings Inc. (PREM)	2025-12-31	$744.6K	+236.5%
ClearPoint Neuro, Inc. (CLPT)	2025-12-31	$814.0K	-16.9%
Cytosorbents Corp (CTSO)	2025-12-31	$1.23M	-7.6%
Retractable Technologies Inc (RVP)	2025-12-31	$7.77M	+2.6%
Interpace Biosciences, Inc. (IDXG)	2025-12-31	$425.0K	+41.7%
Sensus Healthcare, Inc. (SRTS)	2025-12-31	$400.0K	+100.0%
KORU Medical Systems, Inc. (KRMD)	2025-12-31	$810.5K	-8.8%
SS Innovations International, Inc. (SSII)	2025-12-31	$1.08M	+146.8%

Compare OBIO, PREM, CLPT, CTSO side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗